Another important aspect of estrogen signal is that, in female HCC patients, increased expression of miRNA-18a due to elevated/mutant p53 suppresses the protective effect of estrogen by reducing ER-α levels via binding to its mRNA. The gene discussed is ESR1; the disease is hepatocellular carcinoma.